Life Sciences Review

AgencyIQ has been recognized as the Life Sciences Regulation Insights Company of the Year by Life Sciences Review. A division of POLITICO, AgencyIQ was born from a pressing need expressed by subscribers over seven years ago. Today, the business operates as a strategic partner and extension of subscribers’ teams by offering regulatory professionals with reliable access to analysis and insights, real-time data, and non-partisan journalism. “Our vision is to enable businesses to deeply understand, seamlessly track, and effectively engage with regulators to accelerate action and improve outcomes,” says Alexander Gaffney, MS, RAC, Executive Director of Regulatory Policy and Intelligence at AgencyIQ. “POLITICO’s reputation as one of the world’s most trusted sources for high-quality information on politics and policy, combined with its foothold in Brussels, puts AgencyIQ in a strong position to expand geographically, especially in Europe” says Joseph Kenol, AgencyIQ’s Vice President & General Manager. The article will also be featured in the forthcoming special print edition of Life Sciences Regulation Insights 2024. Read More : https://lnkd.in/gW2rumNx #IntelligenceDivision #RegulatoryIntelligence #IndustryRegulation #StrategicPartnerships #GovernmentAffairs

BIOVIIIx has been recognized as the Hemophilia Company of the Year In Europe by Life Sciences Review. BIOVIIIx is a family-run biotech firm that excels in haemophilia and rare diseases. Focusing on scientific research and global partnerships, it rapidly advances treatments and develops innovative solutions. The company invests in employee training, business modernisation and R&D, aiming for international growth through new business units and expanded therapeutic approaches "BIOVIIIx is grounded in ethical and human-centric values. Its decision-making process focuses on projects that directly benefit patients, often foregoing immediate financial gains. This patient-centric approach leads the company to go above and beyond standard practices." says Davide Rosiello, CEO The article will also be featured in the forthcoming special print edition of Hemophilia 2024. Read More : https://lnkd.in/gRB9nJiH #BiotechInnovation #ScientificResearch #HealthcareInnovation #InnovativeTherapies #PharmaResearch #EmployeeTraining

Ivan Salazar, Plant Production Manager, Organigram Contributed an article "The Impact of COVID-19 on Cannabis Consumption: Trends and Future Projections" "As consumers embrace the myriad benefits of cannabis, the future of consumption holds promise for a thriving industry that is increasingly becoming a fundamental part of modern life." says Ivan Salazar The article will also be featured in the forthcoming special print edition of Peptides 2024. Read More : https://lnkd.in/g_sgD3EU #CannabisConsumption #PandemicTrends #CannabisIndustry #PostPandemic

Dae Wook Lee, Medicine, MBA, Medical Director, Pharmaceuticals Korea, Clinical Development and Medical Affairs, Republic of Korea, at Novartis Contributed an article "Implication of Generative AI in Biotechnology" “As the field continues to evolve, the collaboration between generative AI and biotechnology will undoubtedly pave the way for a future where scientific breakthroughs and medical advancements are more accessible and impactful than ever before.” says Dae Wook Lee, The article will also be featured in the forthcoming special print edition of Life Sciences AI 2024. Read More : https://lnkd.in/gji-8Vrj #Biotechnology #BiotechInnovation #MachineLearning #DrugDiscovery #GeneticEngineering #PrecisionMedicine

Helen Yeardley, Senior Vice President, Clinical Operations, ICON, [NASDAQ: ICLR] Contributed an article "The Significant Increase in Demand for Clinical Research Associates (CRAs)" "At ICON, we are looking at how to address this current challenge from number of practical perspectives" says Helen Yeardley The article will also be featured in the forthcoming special print edition of  LSR Public Companies 2024. Read More : https://lnkd.in/gqXiMENU #ClinicalResearch #HealthcareInnovation #HealthTech #BiotechCareers

Ken Lee, General Manager and Region Head, Clinical Development, Asia Pacific, Syneos Health Contributed an article "The simple things in life are still the best, even in clinical development" "This ‘human dimension’ to the work of getting medicines to patients faster deserves more attention from leadership." says Ken Lee The article will also be featured in the forthcoming special print edition of Drug Discovery and Development 2024. Read More : https://lnkd.in/g9_uNhNW #simplicitymatters #clinicalexcellence #healthinnovation #streamlinedprocesses #simplifiedresearch

Ivan A. Salazar, Plant Production Manager, Organigram Inc Contributed an article "The Evolving Landscape of the Cannabis Industry: Sustainability and Innovation" The article will also be featured in the forthcoming special print edition of AI Drug Discovery 2024. Read More : https://lnkd.in/gDc4JZ6d #CannabisIndustry #SustainableCannabis #HempRevolution #SustainableFarming #CleanCannabis

In 1 week Boston will become the epicenter of patient-focused healthcare! On October 15-16, join industry leaders, patient advocates, and healthcare innovators at Pharma & Patient USA 2024 https://bit.ly/3TBYQwt Learn, network, and leave with strategies to truly put patients at the heart of your mission.

The World Drug Safety Congress Americas is right around the corner! As media partners of this year’s event, we’re proud to be a part of the leading event shaping the future of drug safety. This is your chance to join the largest commercial gathering of pharmacovigilance professionals in the world and help make a tangible difference in the drug safety space. When? October 29-30, 2024 Where? Boston Convention & Exhibition Center There’s still time to reserve your spot. Receive 50% off your registration when you book with our exclusive code LSR50. Book now and save: https://lnkd.in/gcCpG5h4 Pharma and biotechs – secure one of the last FREE passes for complimentary event access here: https://lnkd.in/g_QwK7aj

Exciting news for the drug safety community! Life Science Review is honored to be a media partner for the World Drug Safety Congress Americas 2024, happening October 29-30 in Boston! As the #1 drug safety event in the world, this is a can’t-miss event for all pharmacovigilance stakeholders. Meet with FDA, Pfizer, Roche, Johnson & Johnson, and more. Plus, unlock: ✔ Non-stop opportunities to build connections & network with top experts ✔ Keynote sessions with top thought leaders ✔ The latest innovations on our largest expo floor ✔ Presentations across 10 of the most relevant topic areas ✔ Dedicated 1-1 networking zone ✔ Interactive roundtable sessions Special Deal: Get half off your ticket and save $2,000 when you register with our exclusive code LSR50 here: https://lnkd.in/gcCpG5h4 Pharma and biotechs, secure one of the last remaining FREE passes for complimentary event access here: https://lnkd.in/g_QwK7aj #WorldDrugSafety #Pharmacovigilance #DrugSafety #PV #PatientSafety